Pulmatrix, Inc. (PULM) stock
PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.37+0.04 (+3.01%)
Close on Nov 17, 2026Market cap $5.00MP/E –Yield –
Pulmatrix cash
Cash and short-term investments held at the end of each period.
Pulmatrix's cash was $1.40M at Sep 30, 2026. For fiscal 2025 it was $4.09M, down 57.1% from the year before. Over ten years it grew -14.2% a year on average. The highest annual figure on record is $53.84M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.09M | -57.1% |
| FY2024 | Dec 31, 2024 | $9.52M | -50.3% |
| FY2023 | Dec 31, 2023 | $19.17M | -46.2% |
| FY2022 | Dec 31, 2022 | $35.63M | -33.8% |
| FY2021 | Dec 31, 2021 | $53.84M | +70.1% |
| FY2020 | Dec 31, 2020 | $31.66M | +35.1% |
| FY2019 | Dec 31, 2019 | $23.44M | +814.6% |
| FY2018 | Dec 31, 2018 | $2.56M | -31.7% |
| FY2017 | Dec 31, 2017 | $3.75M | -10.2% |
| FY2016 | Dec 31, 2016 | $4.18M | -77.9% |
| FY2015 | Dec 31, 2015 | $18.90M | +4091.1% |
| FY2014 | Dec 31, 2014 | $451.00K | -68.4% |
| FY2013 | Dec 31, 2013 | $1.43M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.40M | -70.8% |
| Q2 FY2026 | Jun 30, 2026 | $2.17M | -62.8% |
| Q1 FY2026 | Mar 31, 2026 | $3.32M | -56.9% |
| Q4 FY2025 | Dec 31, 2025 | $4.09M | -57.1% |
| Q3 FY2025 | Sep 30, 2025 | $4.79M | -55.5% |
| Q2 FY2025 | Jun 30, 2025 | $5.83M | -52.9% |
| Q1 FY2025 | Mar 31, 2025 | $7.71M | -52.7% |
| Q4 FY2024 | Dec 31, 2024 | $9.52M | -50.3% |
| Q3 FY2024 | Sep 30, 2024 | $10.78M | -49.5% |
| Q2 FY2024 | Jun 30, 2024 | $12.38M | -52.0% |
| Q1 FY2024 | Mar 31, 2024 | $16.30M | -47.0% |
| Q4 FY2023 | Dec 31, 2023 | $19.17M | -46.2% |
| Q3 FY2023 | Sep 30, 2023 | $21.34M | -47.6% |
| Q2 FY2023 | Jun 30, 2023 | $25.79M | -39.9% |
| Q1 FY2023 | Mar 31, 2023 | $30.75M | -35.3% |
| Q4 FY2022 | Dec 31, 2022 | $35.63M | -33.8% |
| Q3 FY2022 | Sep 30, 2022 | $40.68M | -23.9% |
| Q2 FY2022 | Jun 30, 2022 | $42.91M | -24.6% |
| Q1 FY2022 | Mar 31, 2022 | $47.53M | -25.1% |
| Q4 FY2021 | Dec 31, 2021 | $53.84M | +70.1% |
| Q3 FY2021 | Sep 30, 2021 | $53.49M | +55.0% |
| Q2 FY2021 | Jun 30, 2021 | $56.90M | +108.8% |
| Q1 FY2021 | Mar 31, 2021 | $63.45M | +160.0% |
| Q4 FY2020 | Dec 31, 2020 | $31.66M | +35.1% |
| Q3 FY2020 | Sep 30, 2020 | $34.51M | +23.8% |
| Q2 FY2020 | Jun 30, 2020 | $27.26M | -14.3% |
| Q1 FY2020 | Mar 31, 2020 | $24.40M | +1037.1% |
| Q4 FY2019 | Dec 31, 2019 | $23.44M | +814.6% |
| Q3 FY2019 | Sep 30, 2019 | $27.88M | +632.5% |
| Q2 FY2019 | Jun 30, 2019 | $31.82M | +281.5% |
| Q1 FY2019 | Mar 31, 2019 | $2.15M | +38.2% |
| Q4 FY2018 | Dec 31, 2018 | $2.56M | -31.7% |
| Q3 FY2018 | Sep 30, 2018 | $3.81M | -40.2% |
| Q2 FY2018 | Jun 30, 2018 | $8.34M | -24.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.55M | -85.3% |
| Q4 FY2017 | Dec 31, 2017 | $3.75M | -10.2% |
| Q3 FY2017 | Sep 30, 2017 | $6.36M | – |
| Q2 FY2017 | Jun 30, 2017 | $10.98M | – |
| Q1 FY2017 | Mar 31, 2017 | $10.54M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.18M | – |
See a number that looks wrong?